Timothy Walbert was appointed chair of the board of directors of Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines.
Does AI still need humans? Is fentanyl airborne? How did certain vaccines and monuments become so […]
Through graduate and continuing studies programs and corporate partnerships, Muhlenberg helps fuel […]
Timothy Walbert was appointed chair of the board of directors of Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines.
